Core Viewpoint - Trump's new healthcare policy continues the idea of reducing government intervention, with recent expressions of imposing tariffs on the pharmaceutical industry, raising questions about the impact on the global healthcare sector and challenges for Chinese pharmaceutical companies [1][3]. Historical Development of the US Healthcare System - The evolution of the US healthcare system can be divided into four stages, focusing on the dual goals of expanding coverage and controlling costs: 1. Emphasis on drug regulation and insurance expansion [5]. 2. Reform of payment methods and increased regulatory flexibility [6]. 3. Strengthened cost control and comprehensive regulation [7]. 4. Promotion of insurance expansion and regulatory informatization [7][14]. Comparison of Healthcare Policies Under Trump and Biden - Trump's administration focused on reducing government intervention, while Biden's administration aimed to strengthen government involvement in healthcare [19][22]. - During Trump's term, healthcare insurance spending remained stable, while Biden's term saw a gradual increase in the proportion of insurance spending [25]. - Employment in the healthcare sector improved under Biden, attributed to the expansion of the Affordable Care Act (ACA) and increased healthcare investment [25]. Future Direction of the US Pharmaceutical Industry - Trump's new term is expected to continue reducing government intervention and promote the return of pharmaceutical manufacturing to the US, impacting the global pharmaceutical landscape [33]. - Domestic implications include potential reductions in insurance coverage and increased out-of-pocket costs for patients, which may lead to decreased pharmaceutical consumption in the short term [33][35]. - Regulatory relaxation may benefit US biotech and generic drug companies, while tariffs on pharmaceutical products could significantly affect imports, particularly from China [3][42]. Impact of Tariffs on Chinese Pharmaceutical Industry - Trump's tariffs aim to protect domestic pharmaceutical manufacturers and suppress the development of Chinese companies, with significant implications for Chinese pharmaceutical exports to the US and Europe [3][45]. - The Chinese pharmaceutical industry primarily exports to the US and Europe, making it vulnerable to tariff increases, especially in the medical device sector [3][45][49]. - The overall export scale of China's pharmaceutical industry is relatively small, with exports to the US and Europe accounting for over 20% [45][46].

特朗普经济学的过去和未来 保时捷又选了位销售专家做中国 CEO 加州迪士尼乐园工会扫除罢工障碍 关注《晚点财经》并设为星标，第一时间获取每日商业精华。 特朗普经济学的过去和未来 拜登上周末宣布退出今年美国总统大选，在民主党选出自己候选人前，日本和韩国股市分别收跌 1.2% 和 1.1%，因为市场降低特朗普胜选预期，卖出可能受益于特朗普美国孤立主义的亚洲盟友们的 股票，在选情不确定的时候先获利了解。 围绕特朗普核心政策主张的交易也被叫做 "特朗普交易" —— 这些政策和特朗普之前做总统时候做成 的和打算做的差不多，核心依然是提高关税、驱逐移民以及减税。若成功实施对应的可能是进口成本 增加、工资上升以及经济过热所带来的加息。 共和党在特朗普右耳中弹前更新的执政纲领，也基本在承诺解决上面这些特朗普提出的标志性议题。 他们谴责 "对全球主义的盲目信仰"，并表示 "共和党必须回归其作为工业、制造业、基础设施和工人 党的根基"。 特朗普已明确计划对所有进口到美国商品征收 10% 关税、但对中国出口商品征 60%，他还威胁要对 中国公司在墨西哥生产的电动车征收 100% 进口关税，尽管美国 2018 年与墨西哥和加拿大达成 ...